Cascadian Therapeutics Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

CASC 0.910 +0.035 (4.00%)
price chart
Company Update (NASDAQ:CASC): Cascadian Therapeutics Inc (USA) Announces ...
casc Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
Cascadian Therapeutics Prices $41.8 Million Concurrent Offerings of Common ...  Investing News Network (press release) (registration) (blog)
Cascadian Therapeutics (NASDAQ:CASC) & ArcelorMittal SA (NYSE:MT) Trending Stocks
On Friday, Shares of Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) lost -3.41% to $0.918. The share price is trading in a range of $0.85 - $0.93.
Notable Analyst's Ranking Preview: Cascadian Therapeutics, Inc. (NASDAQ ...  Street Updates
Mean Price Target Forecast for coming twelve months: Cascadian Therapeutics ...  Is stories
Friday Stock's Trend: Cascadian Therapeutics Inc (USA) (NASDAQ:CASC), SPX ...
Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) went lower by -3.4109% to close at $ 0.9175. The company exchanged total volume of 9.86 million shares throughout course of last trade however it holds an average trading capacity of 1.11 million shares ...
Oncothyreon (ONTY) Changes Name to Cascadian Therapeutics; Will Begin Trading ...
Oncothyreon Inc. (Nasdaq: ONTY) (Nasdaq: CASC) announced that the Company is changing its name to Cascadian Therapeutics, Inc. and will trade on the NASDAQ Global Select Market under the new ticker symbol “CASC,” effective at market open on ...
Oncothyreon Inc (USA) (NASDAQ:ONTY) Will Begin Trading Under New Name ...  Journal Transcript
Oncothyreon Renames Itself Cascadian Therapeutics (NASDAQ:ONTY)  Sonoran Weekly Review
Biotech Beat: Analysts Weigh In On EXACT Sciences Corporation (EXAS ...
Exact shares rallied yesterday on an apparent leaked JAMA article unveiling that USPSTF highly recommends colon cancer screening from age 50 to 75, but will no longer rank tests; instead, it is providing a list of acceptable ones that includes FITDNA ...
Cascadian Therapeutics Says New Data Support Advancement of ONT-380 Study ...
Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) has declined 65.00% since November 5, 2015 and is downtrending. It has underperformed by 64.01% the S&P500.
Oncothyreon Inc.: Cascadian Therapeutics Reports Topline ONT-380 " ...  The Wall Street Transcript
General Electric Company (NYSE:GE) & Cascadian Therapeutics (NASDAQ:CASC ...
The stock is presently trading down its SMA-50 of $1.10. The share price of Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) plunged -75.58% for the year.
Two Buzzers within Analysts Radar: Cascadian Therapeutics, Inc. (NASDAQ:CASC ...  Street Updates
Concentrate on Analyst's Ratings: Cascadian Therapeutics, Inc.'s ...  Is stories
Investor's Alert: Cascadian Therapeutics Inc (NASDAQ:CASC), International ...
On Monday, Share of Cascadian Therapeutics Inc (NASDAQ:CASC), dropped -0.81% and is at $0.910 in the real-time trading session.
Cascadian Therapeutics Announces Exercise of Underwriters'' Over-Allotment ...
SEATTLE, June 28, 2016 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC) today announced that it has closed the previously announced underwritten public offering of 40,250,000 shares of its common stock at a price to the public of ...
BRIEF-Oncothyreon says company is changing its name to Cascadian Therapeutics
June 8 (Reuters) -. * Oncothyreon Inc says company is changing its name to cascadian therapeutics, inc. * Oncothyreon Inc says will trade on nasdaq global select market under new ticker symbol "CASC," effective at market open on June 9, 2016 Source ...